QC
AZN icon

Quent Capital’s AstraZeneca AZN Stock Holding History

Quent Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
590
+37
+7% +$6.96K 0.01% 570
2026
Q1 		$107K Sell
553
-29
-5% -$5.59K 0.01% 532
2025
Q4 		$107K Sell
582
-11
-2% -$1.93K 0.01% 542
2025
Q3 		$90.9K Buy
+593
New +$89.8K 0.01% 460
2025
Q2 		– Sell
-648
Closed -$95.3K – 368
2025
Q1 		$95.3K Sell
648
-32
-5% -$4.63K 0.01% 408
2024
Q4 		$89.1K Sell
680
-14
-2% -$1.96K 0.01% 444
2024
Q3 		$108K Buy
694
+18
+3% +$2.91K 0.01% 483
2024
Q2 		$105K Buy
676
+9
+1% +$1.35K 0.01% 449
2024
Q1 		$90.4K Buy
667
+204
+44% +$27K 0.01% 508
2023
Q4 		$62.3K Buy
463
+92
+25% +$12K 0.01% 567
2023
Q3 		$50.2K Buy
371
+1
+0.3% +$137 0.01% 586
2023
Q2 		$52.9K Buy
370
+11
+3% +$1.62K 0.01% 583
2023
Q1 		$49.8K Buy
359
+1
+0.3% +$135 0.01% 600
2022
Q4 		$48.5K Sell
358
-146
-29% -$18.3K 0.01% 590
2022
Q3 		$55K Hold
504
– – 0.01% 517
2022
Q2 		$67K Buy
504
+36
+8% +$4.72K 0.01% 442
2022
Q1 		$62K Buy
468
+200
+75% +$24K 0.01% 539
2021
Q4 		$31K Buy
+268
New +$31.5K 0.01% 640

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quent Capital's AZN Position: Q2 2026 in Review

Quent Capital increased its AstraZeneca (AZN) stake by 6.7% in Q2 2026, buying an estimated $6.96K and bringing the position to 590 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #570.

Quent Capital first reported a position in AZN in Q4 2021 and has held it in 18 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Quent Capital held 590 shares of AstraZeneca worth $111K as of Q2 2026.
  • Quent Capital bought 37 AstraZeneca shares in Q2 2026, an estimated $6.96K.
  • AstraZeneca made up 0.01% of Quent Capital's portfolio in Q2 2026, its #570 holding.
  • Quent Capital first reported a position in AstraZeneca in Q4 2021 and has held it in 18 quarters since.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.